Key points are not available for this paper at this time.
Design
Review
Supports integrated biomarker monitoring in HF and hypertension; leaves open effects on outcomes pending prospective trials.
With the recent progresses of the information and communication technologies, biosensors and nanotechnologies, the access to continuing health monitoring is becoming real. The development of efficient, accurate and interactive solutions integrating biomarkers for continuing health monitoring might contribute to an improved care of some chronic diseases like hypertension, diabetes or heart failure. Continuing health monitoring might also enhance the efficiency and safety of patient's treatments.
No takes yet. Share an insight, caveat, or question.
Gruson et al. (2012) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: